Global Neurology Academy
The Global Neurology Academy (GNA) series offers certified education modules and video interviews from leading MS experts from across the globe as they address topics such as induction therapy in relapsing-remitting multiple sclerosis; No Evidence of Disease Activity (NEDA) concept; how different agents used in MS management may be utilized in induction therapy; appreciation of how reductions in end-organ damage impact patient quality-of-life; mechanisms of action of the classical as well as emergent agents; key issues associated with making the correct differential diagnosis of multiple sclerosis, in addition to how best to incorporate prognostic indicators into clinical decision-making; current and emergent novel oral agents in MS management; and diagnostic strategies and identifying predictors of outcome.
For more information about GNA, visit www.globalneurologyacademy.org.
226-240 of 249
Jerome Lisk, MD, MBA, M.S., FAAN
Shivashankar Othy, DVM, PhD
Seeking Out Symptoms of Broken Heart Syndrome
NeuroFrontiersSeeking Out Symptoms of Broken Heart Syndrome
Jerome Lisk, MD, MBA, M.S., FAAN
Ilan Wittstein, MD
Refocusing Our Efforts on Advancing Technology to Help Stroke Survivors
NeuroFrontiersRefocusing Our Efforts on Advancing Technology to Help Stroke Survivors
David Weisman, MD
Mijail D Serruya MD,PhD
The Future of Restoring Functionality in Stroke Survivors
NeuroFrontiersThe Future of Restoring Functionality in Stroke Survivors
David Weisman, MD
Mijail D Serruya MD,PhD
Treatment of Progressive MS: Why, Who, When, How
Global Neurology AcademyTreatment of Progressive MS: Why, Who, When, How
Giancarlo Comi, MD
SPECIAL REPORT: Expert Opinion on New MS Drug Approval
Global Neurology AcademySPECIAL REPORT: Expert Opinion on New MS Drug Approval
Prof. Ralf Gold
- advertisement
Now Approved in Europe: First Oral Short-Course Treatment for Highly Active Relapsing MS
Global Neurology AcademyNow Approved in Europe: First Oral Short-Course Treatment for Highly Active Relapsing MS
Cladribine Receives Positive CHMP Opinion for Relapsing MS Treatment
Global Neurology AcademyCladribine Receives Positive CHMP Opinion for Relapsing MS Treatment
The Diagnostic Challenges of Spinal Cord Lesions in MS
CME/CEThe Diagnostic Challenges of Spinal Cord Lesions in MS
Jiwon Oh, MD, PhD
Benefit/Risk Strategies in Selecting Therapeutic Solutions for MS
Global Neurology AcademyBenefit/Risk Strategies in Selecting Therapeutic Solutions for MS
Therapeutic Mechanism of Action (MOAs) in MS: Targeting T- and B-cells to Reset the Immune System
Global Neurology AcademyTherapeutic Mechanism of Action (MOAs) in MS: Targeting T- and B-cells to Reset the Immune System
- advertisement
Multiple Sclerosis Physician Resources
Global Neurology AcademyMultiple Sclerosis Physician Resources
Personalized Approach to Managing MS Patients - Dr. Andrew Chan
Global Neurology AcademyPersonalized Approach to Managing MS Patients - Dr. Andrew Chan
